Predicting Long-Term Mortality in TAVI Patients Using Machine Learning Techniques.

TAVI aortic valve disease machine learning mortality prediction

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 04 02 2021
revised: 19 03 2021
accepted: 13 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Whereas transcatheter aortic valve implantation (TAVI) has become the gold standard for aortic valve stenosis treatment in high-risk patients, it has recently been extended to include intermediate risk patients. However, the mortality rate at 5 years is still elevated. The aim of the present study was to develop a novel machine learning (ML) approach able to identify the best predictors of 5-year mortality after TAVI among several clinical and echocardiographic variables, which may improve the long-term prognosis. We retrospectively enrolled 471 patients undergoing TAVI. More than 80 pre-TAVI variables were collected and analyzed through different feature selection processes, which allowed for the identification of several variables with the highest predictive value of mortality. Different ML models were compared. Multilayer perceptron resulted in the best performance in predicting mortality at 5 years after TAVI, with an area under the curve, positive predictive value, and sensitivity of 0.79, 0.73, and 0.71, respectively. We presented an ML approach for the assessment of risk factors for long-term mortality after TAVI to improve clinical prognosis. Fourteen potential predictors were identified with the organic mitral regurgitation (myxomatous or calcific degeneration of the leaflets and/or annulus) which showed the highest impact on 5 years mortality.

Sections du résumé

BACKGROUND BACKGROUND
Whereas transcatheter aortic valve implantation (TAVI) has become the gold standard for aortic valve stenosis treatment in high-risk patients, it has recently been extended to include intermediate risk patients. However, the mortality rate at 5 years is still elevated. The aim of the present study was to develop a novel machine learning (ML) approach able to identify the best predictors of 5-year mortality after TAVI among several clinical and echocardiographic variables, which may improve the long-term prognosis.
METHODS METHODS
We retrospectively enrolled 471 patients undergoing TAVI. More than 80 pre-TAVI variables were collected and analyzed through different feature selection processes, which allowed for the identification of several variables with the highest predictive value of mortality. Different ML models were compared.
RESULTS RESULTS
Multilayer perceptron resulted in the best performance in predicting mortality at 5 years after TAVI, with an area under the curve, positive predictive value, and sensitivity of 0.79, 0.73, and 0.71, respectively.
CONCLUSIONS CONCLUSIONS
We presented an ML approach for the assessment of risk factors for long-term mortality after TAVI to improve clinical prognosis. Fourteen potential predictors were identified with the organic mitral regurgitation (myxomatous or calcific degeneration of the leaflets and/or annulus) which showed the highest impact on 5 years mortality.

Identifiants

pubmed: 33923465
pii: jcdd8040044
doi: 10.3390/jcdd8040044
pmc: PMC8072967
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

JACC Cardiovasc Interv. 2019 Jul 22;12(14):1328-1338
pubmed: 31320027
J Am Soc Echocardiogr. 2003 Jul;16(7):777-802
pubmed: 12835667
J Am Soc Echocardiogr. 2009 Jan;22(1):1-23; quiz 101-2
pubmed: 19130998
Bone Marrow Transplant. 2014 Mar;49(3):332-7
pubmed: 24096823
Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):110
pubmed: 29425605
Lancet. 2009 Apr 18;373(9672):1382-94
pubmed: 19356795
N Engl J Med. 2020 Feb 27;382(9):799-809
pubmed: 31995682
IEEE Trans Neural Netw. 2009 Dec;20(12):1911-22
pubmed: 19822474
BMC Med Imaging. 2016 May 31;16(1):40
pubmed: 27245048
Circ Cardiovasc Imaging. 2019 Oct;12(10):e009299
pubmed: 31597467
JAMA Netw Open. 2019 Oct 2;2(10):e1915997
pubmed: 31651973
J Thorac Cardiovasc Surg. 2013 Jan;145(1):6-23
pubmed: 23084102
Am J Cardiol. 2019 Aug 1;124(3):423-429
pubmed: 31138402
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Artif Intell Med. 2020 Apr;104:101822
pubmed: 32499001
Am J Cardiol. 2015 Jan 15;115(2):234-42
pubmed: 25432413
Am J Cardiol. 2018 Aug 15;122(4):625-632
pubmed: 30064863
Neth Heart J. 2019 Sep;27(9):443-450
pubmed: 31111457
Int J Cardiol. 2020 Jan 15;299:228-234
pubmed: 31353154
Hypertension. 2014 Dec;64(6):1205-11
pubmed: 25201892
Lancet. 2015 Jun 20;385(9986):2477-84
pubmed: 25788234
Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):389-397
pubmed: 28379513
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Am J Epidemiol. 2019 Dec 31;188(12):2222-2239
pubmed: 31509183
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Int J Cardiol Heart Vasc. 2020 May 22;28:100536
pubmed: 32478166
Circulation. 2017 Jun 20;135(25):e1159-e1195
pubmed: 28298458
J Am Coll Cardiol. 1996 Aug;28(2):515-21
pubmed: 8800133

Auteurs

Marco Penso (M)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Mauro Pepi (M)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Laura Fusini (L)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Manuela Muratori (M)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Claudia Cefalù (C)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Valentina Mantegazza (V)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Paola Gripari (P)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Sarah Ghulam Ali (SG)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Franco Fabbiocchi (F)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.
Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, 20157 Milan, Italy.

Enrico G Caiani (EG)

Department of Electronics, Information and Biomedical Engineering, Politecnico di Milano, 20133 Milan, Italy.

Gloria Tamborini (G)

Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy.

Classifications MeSH